Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs
Authors
Keywords
-
Journal
Nature Reviews Cardiology
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-24
DOI
10.1038/s41569-018-0080-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)
- (2018) Warren H. Capell et al. AMERICAN HEART JOURNAL
- Use of non-vitamin K oral anticoagulants in people with atrial fibrillation and diabetes mellitus
- (2018) O. Itzhaki Ben Zadok et al. DIABETIC MEDICINE
- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Stuart J Connolly et al. LANCET
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Sonia S Anand et al. LANCET
- Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
- (2018) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- Anemia contributes to cardiovascular disease through reductions in nitric oxide
- (2017) Felicita Andreotti et al. JOURNAL OF APPLIED PHYSIOLOGY
- Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus
- (2017) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation
- (2017) Giuseppe Patti et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
- (2017) William R. Hiatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation
- (2017) Cristina Barale et al. THROMBOSIS AND HAEMOSTASIS
- Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus
- (2016) Paul A. Gurbel et al. AMERICAN JOURNAL OF CARDIOLOGY
- Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery DiseaseCLINICAL PERSPECTIVE
- (2016) Marc P. Bonaca et al. CIRCULATION
- Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery DiseaseClinical Perspective
- (2016) Francesco Franchi et al. CIRCULATION
- Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy StudyCLINICAL PERSPECTIVE
- (2016) Ian T. Meredith et al. CIRCULATION
- Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus
- (2016) Davide Capodanno et al. CIRCULATION
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- (2016) Marie D. Gerhard-Herman et al. CIRCULATION
- Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes MellitusClinical Perspective
- (2016) Yoshihiko Saito et al. CIRCULATION
- Glucagon-Like Peptide 1 Receptor Activation Attenuates Platelet Aggregation and Thrombosis
- (2016) Alison Cameron-Vendrig et al. DIABETES
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism
- (2016) Andrew D Blann et al. HEART
- Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS–TIMI 54
- (2016) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients
- (2016) Jeffrey M. Ashburner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
- (2016) Marc P. Bonaca et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
- (2016) Glenn N. Levine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor reduces cardiac events in patients with PAD or diabetes
- (2016) Karina Huynh Nature Reviews Cardiology
- Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease
- (2016) Davide Capodanno et al. Nature Reviews Cardiology
- Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
- (2016) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- On-treatment platelet reactivity: State of the art and perspectives
- (2016) Rossella Marcucci et al. VASCULAR PHARMACOLOGY
- Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials
- (2016) Giuseppe Gargiulo et al. BMJ-British Medical Journal
- Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials
- (2016) Giuseppe Gargiulo et al. BMJ-British Medical Journal
- Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction: Findings From the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events-TIMI 50 Trial
- (2015) M. A. Cavender et al. CIRCULATION
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
- (2015) Caroline S. Fox et al. DIABETES CARE
- Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes
- (2015) M. A. Bethel et al. DIABETIC MEDICINE
- Prognostic impact of high residual platelet reactivity after chronic total occlusion percutaneous coronary intervention in patients with diabetes mellitus
- (2015) Renato Valenti et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
- (2015) Faiez Zannad et al. LANCET
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aspirin for primary prevention in diabetes mellitus: from the calculation of cardiovascular risk and risk/benefit profile to personalised treatment
- (2015) Francesca Santilli et al. THROMBOSIS AND HAEMOSTASIS
- Metformin reduces hyper-reactivity of platelets from patients with polycystic ovary syndrome by improving mitochondrial integrity
- (2015) Amro Elgheznawy et al. THROMBOSIS AND HAEMOSTASIS
- Impact of Intensive Glycemic Control on the Incidence of Atrial Fibrillation and Associated Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)
- (2014) Omid Fatemi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Glycated Albumin With Loss of Fatty Acid Binding Capacity Contributes to Enhanced Arachidonate Oxygenation and Platelet Hyperactivity: Relevance in Patients With Type 2 Diabetes
- (2014) Denis Blache et al. DIABETES
- Management of venous thrombo-embolism: an update
- (2014) Stavros Konstantinides et al. EUROPEAN HEART JOURNAL
- Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk Factors
- (2014) Yasuo Ikeda et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease
- (2014) Dominick J. Angiolillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of High On-treatment Platelet Reactivity in Diabetic Patients Treated with Aspirin
- (2013) Scot H. Simpson et al. AMERICAN JOURNAL OF MEDICINE
- Vorapaxar in Patients With Peripheral Artery Disease
- (2013) Marc P. Bonaca et al. CIRCULATION
- Antiplatelet Therapy in Patients With Diabetes Mellitus and Acute Coronary Syndrome
- (2013) Giuseppe Patti et al. CIRCULATION JOURNAL
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2013) EUROPEAN HEART JOURNAL
- Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation
- (2013) Fabiana Rollini et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
- (2013) Yongjun Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome
- (2013) Marc Laine et al. THROMBOSIS AND HAEMOSTASIS
- Randomized Comparison of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome and Planned Invasive Strategy—Design and Rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial
- (2013) Stefanie Schulz et al. Journal of Cardiovascular Translational Research
- Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
- (2013) L. A. Castellucci et al. BMJ-British Medical Journal
- Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease
- (2012) Jean-Guillaume Dillinger et al. AMERICAN HEART JOURNAL
- Venous Thromboembolism in Patients with Diabetes Mellitus
- (2012) Gregory Piazza et al. AMERICAN JOURNAL OF MEDICINE
- Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on-treatment platelet reactivity and diabetes mellitus status
- (2012) Piera Capranzano et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
- (2012) J. A. Johnson et al. DIABETOLOGIA
- Association of Aspirin Use With Major Bleeding in Patients With and Without Diabetes
- (2012) Giorgia De Berardis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes
- (2012) B. ROCCA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
- (2012) Matthew T. Roe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-Analysis of Cohort and Case–Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial Fibrillation
- (2011) Rachel R. Huxley et al. AMERICAN JOURNAL OF CARDIOLOGY
- Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
- (2011) José Luis Ferreiro et al. CIRCULATION
- Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease
- (2011) Davide Capodanno et al. Circulation-Cardiovascular Interventions
- A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial
- (2011) D. J. Angiolillo et al. EUROPEAN HEART JOURNAL
- ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)
- (2011) et al. EUROPEAN HEART JOURNAL
- Effect of Clopidogrel plus ASA vs. ASA Early after TIA and Ischaemic Stroke: A Substudy of the CHARISMA Trial
- (2011) Graeme J. Hankey et al. International Journal of Stroke
- Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
- (2011) Marie-Germaine Bousser et al. LANCET
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional profile of the platelet P2Y12 receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease
- (2011) Masafumi Ueno et al. THROMBOSIS AND HAEMOSTASIS
- Diabetes mellitus and thrombosis
- (2011) Natale Vazzana et al. THROMBOSIS RESEARCH
- Comparison of Platelet Reactivity and Periprocedural Outcomes in Patients With Versus Without Diabetes Mellitus and Treated With Clopidogrel and Percutaneous Coronary Intervention
- (2010) Fabio Mangiacapra et al. AMERICAN JOURNAL OF CARDIOLOGY
- Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes
- (2010) Michael Pignone et al. CIRCULATION
- Review article: Coagulation and fibrinolysis in diabetes
- (2010) SH Alzahrani et al. Diabetes & Vascular Disease Research
- Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2010) Stefan James et al. EUROPEAN HEART JOURNAL
- Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial IndexA Randomized Controlled Trial
- (2010) F. Gerald R. Fowkes JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
- (2010) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: A randomized, controlled study
- (2009) Yaling Han et al. AMERICAN HEART JOURNAL
- Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] Trial)
- (2009) Arijit Dasgupta et al. AMERICAN JOURNAL OF CARDIOLOGY
- Is Diabetes Mellitus an Independent Risk Factor for Venous Thromboembolism?
- (2009) John A. Heit et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- (2009) Kang-Yin Chen et al. CIRCULATION
- Aspirin for the Primary Prevention of Cardiovascular Events: A systematic review and meta-analysis comparing patients with and without diabetes
- (2009) A. D. Calvin et al. DIABETES CARE
- Patients with peripheral arterial disease in the CHARISMA trial
- (2009) P. P. Cacoub et al. EUROPEAN HEART JOURNAL
- Altered expression of CYP in TSOD mice: a model of type 2 diabetes and obesity
- (2009) T. Kudo et al. XENOBIOTICA
- Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention
- (2008) Giuseppe G.L. Biondi-Zoccai et al. AMERICAN HEART JOURNAL
- Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- (2008) Stephen D. Wiviott et al. CIRCULATION
- Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome
- (2008) A. Undas et al. DIABETES CARE
- Is diabetes a coronary risk equivalent? Systematic review and meta-analysis
- (2008) U. Bulugahapitiya et al. DIABETIC MEDICINE
- A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study
- (2008) D. J. Angiolillo et al. EUROPEAN HEART JOURNAL
- Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial
- (2008) Hisao Ogawa JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo
- (2008) David Erlinge et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus
- (2008) Seung-Whan Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
- (2008) Alexander T Cohen et al. LANCET
- Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke
- (2008) Ralph L. Sacco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of P2Y12 Inhibitory Effects Induced by Clopidogrel on Platelet Procoagulant Activity in Type 2 Diabetes Mellitus Patients
- (2008) Dominick J. Angiolillo et al. THROMBOSIS RESEARCH
- Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus—An effect probably mediated by direct platelet PPARγ activation
- (2007) M.P. Khanolkar et al. ATHEROSCLEROSIS
- Randomized Comparison of Cilostazol vs Clopidogrel After Drug-Eluting Stenting in Diabetic Patients
- (2007) Youngkeun Ahn et al. CIRCULATION JOURNAL
- Decreasedin vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects
- (2007) Gloria Formoso et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now